Peptide Therapy Candidates: Individuals focused on recovery, sleep, lean mass, body composition support , or joint/soft-tissue comfort
Why Human Pregnancy Data for GLP-1 Medications Remains Limited GLP-1 receptor agonists were not approved for weight loss until 2021 (semaglutide) and later (tirzepatide), making the pool of pregnant exposures relatively small
Understanding Hair Loss Associated with GLP-1 Medications Hair thinning or increased shedding may occur in some individuals during or following treatment with GLP-1 medications
How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test may help provide context about your predisposition in metabolic and appetite-regulation pathwaysspecifically variants in GLP1R, GIPR, FTO, and MC4R genes
Risk Factors to Be Aware Of Certain factors may increase your likelihood of experiencing this concern: Check your GLP-1 eligibility Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy
What lifestyle changes can help boost my glutathione levels
